Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation

Blood

Volumn 120, Issue 24, 2012, Pages 4873-4881

  Huang, Jie ^a   Sabater Lleal, Maria ^b   Asselbergs, Folkert W ^c   Tregouet, David ^d   Shin, So Youn ^e   Ding, Jingzhong ^f   Baumert, Jens ^g   Oudot Mellakh, Tiphaine ^d   Folkersen, Lasse ^b   Johnson, Andrew D ^a,h   Smith, Nicholas L ^i,j,k   Williams, Scott M ^l   Ikram, Mohammad A ^m   Kleber, Marcus E ^n,o   Becker, Diane M ^p   Truong, Vinh ^d   Mychaleckyj, Josyf C ^q   Tang, Weihong ^r   Yang, Qiong ^a,s   Sennblad, Bengt ^b   Moore, Jason H ^t   Williams, Frances M K ^u   Dehghan, Abbas ^m,v   Silbernagel, Günther ^w   Schrijvers, Elisabeth M C ^m,v   Smith, Shelly ^f   Karakas, Mahir ^x   Tofler, Geoffrey H ^y   Silveira, Angela ^b   Navis, Gerjan J ^z   Lohman, Kurt ^f   Chen, Ming Huei ^s   Peters, Annette ^g   Goel, Anuj ^aa,ab   Hopewell, Jemma C ^ab   Chambers, John C ^ac,ad   Saleheen, Danish ^ae,af   Lundmark, Per ^ag   Psaty, Bruce M ^i,j   Strawbridge, Rona J ^b   Boehm, Bernhard O ^ah   Carter, Angela M ^ai   Meisinger, Christa ^g   Peden, John F ^aa,ab   Bis, Joshua C ^aj   McKnight, Barbara ⁱ   Öhrvik, John ^b   Taylor, Kent ^ak   Franzosi, Maria Grazia ^al   Seedorf, Udo ^am   Collins, Rory ^ab   Franco Cereceda, Anders ^an   Syvänen, Ann Christine ^ag   Goodall, Alison H ^ao   Yanek, Lisa R ^p   Cushman, Mary ^ap   Müller Nurasyid, Martina ^g,aq,ar   Folsom, Aaron R ^r   Basu, Saonli ^r   Matijevic, Nena ^as   Van Gilst, Wiek H ^z   Kooner, Jaspal S ^ad   Hofman, Albert ^m,v   Danesh, John ^af   Clarke, Robert ^ab   Meigs, James B ^at,au   Kathiresan, Sekar ^at,av   Reilly, Muredach P ^aw   Klopp, Norman ^g   Harris, Tamara B ^ax   Winkelmann, Bernhard R ^ay   Grant, Peter J ^ai   Hillege, Hans L ^z   Watkins, Hugh ^aa,ab   Spector, Timothy D ^u   Becker, Lewis C ^p   Tracy, Russell P ^az   März, Winfried ^o,ba,bb   Uitterlinden, Andre G ^m,v   Eriksson, Per ^b   Cambien, Francois ^d   Morange, Pierre Emmanuel ^d   Koenig, Wolfgang ^x   Soranzo, Nicole ^e,u   Van Der Harst, Pim ^z   Liu, Yongmei ^f   O'Donnell, Christopher J ^a,h,au   Hamsten, Anders ^b   more..

^a FRAMINGHAM HEART STUDY   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d INSERM   (France)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j CENTER FOR HEALTH STUDIES   (United States)

^k Seattle Epidemiologic Research and Information Center   (United States)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m ERASMUS MEDICAL CENTER   (Netherlands)

ⁿ Ludwigshafen Risk and Cardiovascular Health   (Germany)

^o MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q UNIVERSITY OF VIRGINIA   (United States)

^r UNIVERSITY OF MINNESOTA   (United States)

^s BOSTON UNIVERSITY   (United States)

^t DARTMOUTH MEDICAL SCHOOL   (United States)

^u KING'S COLLEGE LONDON   (United Kingdom)

^v Netherlands Consortium for Healthy Ageing   (Netherlands)

^w UNIVERSITY OF TÜBINGEN   (Germany)

^x UNIVERSITY HOSPITAL ULM   (Germany)

^y UNIVERSITY OF SYDNEY   (Australia)

^z UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^aa UNIVERSITY OF OXFORD   (United Kingdom)

^ab UNIVERSITY OF OXFORD   (United Kingdom)

^ac IMPERIAL COLLEGE LONDON   (United Kingdom)

^ad EALING HOSPITAL NHS TRUST   (United Kingdom)

^ae Center for Non Communicable Diseases Pakistan   (Pakistan)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag UPPSALA UNIVERSITY   (Sweden)

^ah UNIVERSITY OF ULM   (Germany)

^ai UNIVERSITY OF LEEDS   (United Kingdom)

^aj UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^ak CEDARS SINAI MEDICAL CENTER   (United States)

^al MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^am UNIVERSITY OF MÜNSTER   (Germany)

^an KAROLINSKA INSTITUTE   (Sweden)

^ao UNIVERSITY OF LEICESTER   (United Kingdom)

^ap UNIVERSITY OF VERMONT   (United States)

^aq UNIVERSITY OF MUNICH   (Germany)

^ar LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^as UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^at MASSACHUSETTS GENERAL HOSPITAL   (United States)

^au HARVARD MEDICAL SCHOOL   (United States)

^av MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^aw UNIVERSITY OF PENNSYLVANIA   (United States)

^ax NATIONAL INSTITUTE ON AGING   (United States)

^ay Cardiology Group Sachsenhausen   (Germany)

^az UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^ba SYNLAB ACADEMY   (Germany)

^bb MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AORTA; ARNTL GENE; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTICLE; CHROMOSOME 11P; CHROMOSOME 3P; CHROMOSOME 7Q; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; MACROPHAGE; MAJOR CLINICAL STUDY; MAMMARY ARTERY; MONOCYTE; MUC3 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PPARG GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SERPINE1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIP6 GENE;

EID: 84870738355     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-436188     Document Type: Article

References (37)

1. Aznar J, Estelles A, Tormo G, et al. Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br Heart J. 1988;59(5):535-541.
2. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2(8549):3-9. (Pubitemid 17083665)
3. Hamsten A, Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 1985;313(25):1557-1563. (Pubitemid 16177394)
4. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med. 2000;342(24):1792-1801. (Pubitemid 30390240)
5. Lupu F, Bergonzelli GE, Heim DA, et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb. 1993;13(7):1090-1100. (Pubitemid 23195812)
6. Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A. 1992;89(15):6998-7002.
7. Alessi MC, Juhan-Vague I. Pai-1 and the metabolic syndrome: Links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006;26(10):2200-2207. (Pubitemid 44465712)
8. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes. 2002;51(4):1131-1137. (Pubitemid 34438360)
9. Festa A, Williams K, Tracy RP, Wagenknecht LE, Haffner SM. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation. 2006;113(14):1753-1759. (Pubitemid 43958468)
10. Cesari M, Sartori MT, Patrassi GM, Vettore S, Rossi GP. Determinants of plasma levels of plasminogen activator inhibitor-1: A study of normotensive twins. Arterioscler Thromb Vasc Biol. 1999;19(2):316-320. (Pubitemid 29072745)
11. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: A twin study. Lancet. 2001;357(9250):101-105. (Pubitemid 32094912)
12. Kathiresan S, Gabriel SB, Yang Q, et al. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels. Circulation. 2005;112(12):1728-1735. (Pubitemid 41368148)
13. Yang Q, Kathiresan S, Lin JP, Tofler GH, O'Donnell CJ. Genome-wide association and linkage analyses of hemostatic factors and hematologic phenotypes in the framingham heart study. BMC Med Genet. 2007;8(suppl 1):S12.
14. Henry M, Tregouet DA, Alessi MC, et al. Metabolic determinants are much more important than genetic polymorphisms in determining the pai-1 activity and antigen plasma concentrations: A family study with part of the stanislas cohort. Arterioscler Thromb Vasc Biol. 1998;18(1):84-91. (Pubitemid 28047603)
15. Boekholdt SM, Bijsterveld NR, MoonsAH, Levi M, Buller HR, Peters RJ. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: A systematic review. Circulation. 2001;104(25):3063-3068. (Pubitemid 34014058)
16. Koch W, Schrempf M, Erl A, et al. 4g/5g polymorphism and haplotypes of serpine1 in atherosclerotic diseases of coronary arteries. Thromb Haemost. 2010;103(6):1170-1180.
17. Lanktree MB, Johansen CT, Anand SS, et al. Genetic variation in hyaluronan metabolism loci is associated with plasma plasminogen activator inhibitor-1 concentration. Blood. 2010;116(12):2160-2163.
18. Schunkert H, König IR, Kathiresan S, et al; The CardioGram Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333-338.
19. Peden JF, Hopewell JC, Saleheen D, et al The Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in europeans and south asians identifies five new loci for coronary artery disease. Nat Genet. 2011;43(4):339-344.
20. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genomewide association studies by imputation of genotypes. Nat Genet. 2007;39(7):906-913. (Pubitemid 47014502)
21. Servin B, Stephens M. Imputation-based analysis of association studies: Candidate regions and quantitative traits. PLoS Genet. 2007;3(7):e114.
22. Chen MH, Yang Q. Gwaf: An R package for genome-wide association analyses with family data. Bioinformatics. 2010;26(4):580-581.
23. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579-589.
24. Heinig M, Petretto E, Wallace C, et al. A transacting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature. 2010;467(7314):460-464.
25. Folkersen L, van't Hooft F, Chernogubova E, et al. Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet. 2010;3(4):365-373.
26. Zeller T, Wild P, Szymczak S, et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One. 2010;5(5):e10693.
27. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995;92(6):1851-1855.
28. Volin MV, Shahrara S, Haines GK, Woods JM 3rd, Koch AE. Expression of mucin 3 and mucin 5ac in arthritic synovial tissue. Arthritis Rheum. 2008;58(1):46-52.
29. Kyo K, Muto T, Nagawa H, Lathrop GM, Nakamura Y. Associations of distinct variants of the intestinal mucin gene muc3a with ulcerative colitis and crohn's disease. J Hum Genet. 2001;46(1):5-20. (Pubitemid 32178919)
30. Oishi K. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders. Clin Exp Hypertens. 2009;31(3):208-219.
31. Maemura K, de la Monte SM, Chin MT, et al. Clif, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem. 2000;275(47):36847-36851. (Pubitemid 32002096)
32. Schoenhard JA, Smith LH, Painter CA, Eren M, Johnson CH, Vaughan DE. Regulation of the pai-1 promoter by circadian clock components: Differential activation by bmal1 and bmal2. J Mol Cell Cardiol. 2003;35(5):473-481. (Pubitemid 36539453)
33. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin j2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 1995;83(5):813-819. (Pubitemid 3006325)
34. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. Ppargamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: Ppargamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999;19(3):546-551. (Pubitemid 29135154)
35. Zirlik A, Leugers A, Lohrmann J, et al. Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinediones. Thromb Haemost. 2004;91(4):674-682. (Pubitemid 38477446)
36. Suzuki Y, Urano T, Ihara H, et al. Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger rna by a combination of mono-unsaturated fatty acid and insulin in hepg2 cells. Life Sci. 2001;68(16):1827-1837. (Pubitemid 32245607)
37. Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost. 2005;3(1):35-45. (Pubitemid 41647113)